Gayatri BioOrga.

  • Market Cap: Micro Cap
  • Industry: Commodity Chemicals
  • ISIN: INE052E01015
  • NSEID:
  • BSEID: 524564
INR
20.00
0.19 (0.96%)
BSENSE

May 06

BSE+NSE Vol: 27.8 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 503586,
    "name": "Gayatri BioOrga.",
    "stock_name": "Gayatri BioOrga.",
    "full_name": "Gayatri BioOrganics Ltd",
    "name_url": "stocks-analysis/gayatri-bioorga",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "20.00",
    "chg": 0.19,
    "chgp": "0.96%",
    "dir": 1,
    "prev_price": "19.81",
    "mcapval": "151.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524564,
    "symbol": "",
    "ind_name": "Commodity Chemicals",
    "ind_code": 11,
    "indexname": "India SENSEX",
    "isin": "INE052E01015",
    "curr_date": "May 06",
    "curr_time": "",
    "bse_nse_vol": "27.8 k",
    "exc_status": "Active",
    "traded_date": "May 06, 2026",
    "traded_date_str": "2026 05 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gayatri-bioorga-503586-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Gayatri BioOrganics Ltd to 52-Week High of Rs 20",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gayatri-bioorganics-ltd-hits-new-52-week-high-at-rs20-3977311",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GayatriBioOrgan_priceRelatedfactors_3977311.png",
        "date": "2026-05-06 09:43:45",
        "description": "Surging from a 52-week low of Rs 6.13 to a fresh high of Rs 20, Gayatri BioOrganics Ltd has delivered an impressive 182.45% return over the past year, significantly outperforming the Sensex which declined by 4.09% during the same period. This milestone reflects a powerful technical momentum that has propelled the stock well above its key moving averages."
      },
      {
        "title": "Gayatri BioOrganics Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gayatri-bioorganics-ltd-is-rated-sell-3966527",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GayatriBioOrgan_mojoScore_3966527.png",
        "date": "2026-04-28 10:10:03",
        "description": "Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing."
      },
      {
        "title": "Gayatri BioOrganics Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gayatri-bioorganics-ltd-is-rated-sell-3950824",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GayatriBioOrgan_mojoScore_3950824.png",
        "date": "2026-04-17 10:10:03",
        "description": "Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Gayatri BioOrganics Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gayatri-bioorganics-ltd-is-rated-sell-3934159",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GayatriBioOrgan_mojoScore_3934159.png",
        "date": "2026-04-06 10:10:28",
        "description": "Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Gayatri BioOrganics Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gayatri-bioorganics-ltd-is-rated-sell-3917956",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GayatriBioOrgan_mojoScore_3917956.png",
        "date": "2026-03-26 10:10:02",
        "description": "Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Gayatri BioOrganics Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gayatri-bioorganics-ltd-is-rated-sell-3892219",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GayatriBioOrgan_mojoScore_3892219.png",
        "date": "2026-03-15 10:10:02",
        "description": "Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Gayatri BioOrganics Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gayatri-bioorganics-ltd-is-rated-sell-by-marketsmojo-3866228",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GayatriBioOrgan_mojoScore_3866228.png",
        "date": "2026-03-03 10:10:34",
        "description": "Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 05 May 2025, but the analysis below reflects the stock's current position as of 03 March 2026, incorporating the latest fundamentals, returns, and financial metrics."
      },
      {
        "title": "Gayatri BioOrganics Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gayatri-bioorganics-ltd-is-rated-sell-3848124",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GayatriBioOrgan_mojoScore_3848124.png",
        "date": "2026-02-20 10:10:34",
        "description": "Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 20 February 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Are Gayatri BioOrganics Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-gayatri-bioorganics-ltd-latest-results-good-or-bad-3831435",
        "imagepath": "",
        "date": "2026-02-10 19:21:08",
        "description": "Gayatri BioOrganics Ltd's latest financial results indicate a troubling situation for the company. The firm has reported zero net sales for the seventh consecutive quarter, reflecting a complete operational shutdown since June 2024. In the most recent quarter, Q3 FY26, the company incurred a net loss of ₹0.22 crores, which is a marginal increase from the previous quarter's loss of ₹0.21 crores. This trend of mounting losses is compounded by a negative shareholder equity of ₹35.89 crores and a negative book value of ₹4.56 per share, highlighting severe financial distress.\n\nThe data reveals that the company's operating margin remains at 0.0%, consistent with its lack of operational activity. Employee costs and interest expenses persist despite the absence of revenue, indicating ongoing financial obligations that further strain the company's resources. The accumulated losses for the nine-month period of FY2026..."
      }
    ],
    "total": 144,
    "sid": "503586",
    "stock_news_url": "https://www.marketsmojo.com/news/gayatri-bioorganics-503586"
  },
  "announcements": [
    {
      "caption": "Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2",
      "datetime": "01-May-2026",
      "details": "<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr> <td>1</td> <td>Name of Company</td> <td>Gayatri BioOrganics Ltd</td> </tr> <tr> <td>2</td> <td>CIN NO.</td> <td>L24110TG1991PLC013512</td> </tr> <tr> <td>3</td> <td>Report filed for FY</td> <td>2025-2026</td> </tr> <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr> <td>4</td> <td>2 - year block period (Specify financial years)* </td> <td>FY 2025-26 2026-27</td> </tr> <tr> <tr> <td>5</td> <td>Incremental borrowing done in FY (T)(a) </td> <td>0.00</td> </tr> <tr> <td>6</td> <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td> <td>0.00</td> </tr> <tr> <td>7</td> <td>Actual borrowing done through debt securities in FY (T)(c)</td> <td>0.00</td> </tr> <tr> <td>8</td> <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td> <td>0</td> </tr> <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td> <td>0</td> </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td> <td>0</td> </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>FY 2024-25 2025-26</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div> <br/><br/><br/> <table><tr><td>Name of the Company Secretary :-</td><td>Huda Khan</td></tr><tr><td>Designation :-</td><td>Company Secretary and Compliance Officer</td></tr> <tr><td>Name of the Chief Financial Officer :- </td><td>Achanta Prabhakar Rao</td></tr> <tr><td>Designation : -</td><td>CFO</td></tr></table><div> <br/> Date: 01/05/2026<br/><br/></div>",
      "source": "BSE"
    },
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "30-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Gayatri BioOrganics Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24110TG1991PLC013512</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>2.07</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Huda Khan <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: info@gayatribioorganics.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Achanta Prabhakar Rao <br/> Designation: CFO <br/> EmailId: info@gayatribioorganics.com</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "11-Apr-2026",
      "details": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations2018.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

01-May-2026 | Source : BSE

Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1 Name of Company Gayatri BioOrganics Ltd
2 CIN NO. L24110TG1991PLC013512
3 Report filed for FY 2025-2026
Details of the Current block (all figures in Rs crore):
4 2 - year block period (Specify financial years)* FY 2025-26 2026-27
5 Incremental borrowing done in FY (T)(a) 0.00
6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00
7 Actual borrowing done through debt securities in FY (T)(c) 0.00
8 Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d) 0
8Quantum of (d) which has been met from (c)(e)* 0
9 Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}* 0


Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):
2 - year Block period (Specify financial years)FY 2024-25 2025-26
Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#0.00



Name of the Company Secretary :-Huda Khan
Designation :-Company Secretary and Compliance Officer
Name of the Chief Financial Officer :- Achanta Prabhakar Rao
Designation : -CFO

Date: 01/05/2026

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

30-Apr-2026 | Source : BSE

Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompanyGayatri BioOrganics Ltd
2CIN NO.L24110TG1991PLC013512
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 2.07
4Highest Credit Rating during the previous FY NA
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



Name of the Company Secretary: Huda Khan
Designation: Company Secretary and Compliance Officer
EmailId: info@gayatribioorganics.com
Name of the Chief Financial Officer: Achanta Prabhakar Rao
Designation: CFO
EmailId: info@gayatribioorganics.com

Date: 30/04/2026

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

11-Apr-2026 | Source : BSE

Certificate under Reg. 74 (5) of SEBI (DP) Regulations2018.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available